Seville, Spain 1st July 2022
This scientific seminar aims to meet basic and clinical researchers, together with industry and administration representatives, to explore and discuss inflammation and immunity in health and in pathological processes. Our aim is to promote a debate on research in these fields and to stimulate the translation of research findings into novel therapeutic applications. It will be an opportunity to forge new scientific collaborations within our environment and to favour the bases for future activities and joint projects. This IV edition will be held as a hybrid session involving both in-person and virtual participation.
June 21st – deadline for registration https://forms.office.com/r/QtvKQDPExk
Dr. Francisco Javier Ávila Román
Dr. Virginia Motilva Sánchez
Dr. Ma Ángeles Rosillo Ramírez
Dr. Marina Sánchez Hidalgo
Dr. Elena Ma Talero Barrientos
Sara García Gil
Rocío Muñoz García
Department of Pharmacology Faculty of Pharmacy University of Seville https://departamento.us.es/dfarmaco/
9:15- 9:30 Opening
Committee of Honour
9:30-10:00 New perspectives in psoriasis management
Dr. Isabel Belinchón, University General Hospital Dr. Balmis of Alicante-ISABIAL/ Miguel Hernández University, Elche, Spain
Dr. José Luis Calleja, San Cecilio Hospital/University of Granada, Granada, Spain
10:30-11:00 Epigenetic regulation of inflammatory mechanisms in osteoarthritis Dr. María del Carmen de Andrés González, Biomedical Research Institute of A Coruña-INIBIC, A Coruña-CHUAC University Hospital, Coruña, Spain
12:00-12:30 Human immune cells across tissues
Dr. Cecilia Domínguez Conde. Centre for Genomics, Human Technopole. Milan, Italy.
12:30-13:00 Impact of lifestyle on obesity-associated inflammation
Dr. María Rosa Bernal López, Biomedical Research Coordinator of Clinical Management Unit of Internal Medicine. Regional University Hospital of Málaga/IBIMA-Plataforma Bionand, Málaga, Spain.
13:00-13:30 Molecular mechanisms involved in metabolic comorbidities and cardiovascular risk in inflammatory arthritis. Effect of conventional drugs and new biological therapies
Dr. Nuria Barbarroja, Maimonides Institute for Biomedical Research of Cordoba (IMIBIC), University of Córdoba, Córdoba, Spain.
16:30-17:00 Disruption of mitochondrial complex I induces progressive parkinsonism Dr. Patricia González Rodríguez. Instituto de Biomedicina de Sevilla (IBiS)/University of Seville, Seville, Spain.
17:00-17:30 Knowledge transfer from the University to the industry
Dr. Azahara Mª Rodríguez Luna. SENSAR, University Hospital of Alcorcón Foundation Madrid, Spain. 17:30-18:00 Innovative strategies to search for active principles from ancestral medicinal plants. Dr. Mario Armando Gómez Hurtado. Michoacan University of Saint Nicholas of Hidalgo, México.
18:00-18:30 Closure and delivery of certificate of attendance